BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

405 related articles for article (PubMed ID: 28760462)

  • 1. Histone Modification Is Correlated With Reverse Left Ventricular Remodeling in Nonischemic Dilated Cardiomyopathy.
    Ito E; Miyagawa S; Fukushima S; Yoshikawa Y; Saito S; Saito T; Harada A; Takeda M; Kashiyama N; Nakamura Y; Shiozaki M; Toda K; Sawa Y
    Ann Thorac Surg; 2017 Nov; 104(5):1531-1539. PubMed ID: 28760462
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cardiac unloading by LVAD support differentially influences components of the cGMP-PKG signaling pathway in ischemic and dilated cardiomyopathy.
    Persoon S; Paulus M; Hirt S; Jungbauer C; Dietl A; Luchner A; Schmid C; Maier LS; Birner C
    Heart Vessels; 2018 Aug; 33(8):948-957. PubMed ID: 29546540
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Brain natriuretic peptide is produced both by cardiomyocytes and cells infiltrating the heart in patients with severe heart failure supported by a left ventricular assist device.
    Bruggink AH; de Jonge N; van Oosterhout MF; Van Wichen DF; de Koning E; Lahpor JR; Kemperman H; Gmelig-Meyling FH; de Weger RA
    J Heart Lung Transplant; 2006 Feb; 25(2):174-80. PubMed ID: 16446217
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biventricular assist device-induced right ventricular reverse structural and functional remodeling.
    Klotz S; Naka Y; Oz MC; Burkhoff D
    J Heart Lung Transplant; 2005 Sep; 24(9):1195-201. PubMed ID: 16143233
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Altered myocardial phenotype after mechanical support in human beings with advanced cardiomyopathy.
    Altemose GT; Gritsus V; Jeevanandam V; Goldman B; Margulies KB
    J Heart Lung Transplant; 1997 Jul; 16(7):765-73. PubMed ID: 9257259
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Left ventricular reverse remodeling with a continuous flow left ventricular assist device measured by left ventricular end-diastolic dimensions and severity of mitral regurgitation.
    Morgan JA; Brewer RJ; Nemeh HW; Murthy R; Williams CT; Lanfear DE; Tita C; Paone G
    ASAIO J; 2012; 58(6):574-7. PubMed ID: 23103696
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mechanical unloading during left ventricular assist device support increases left ventricular collagen cross-linking and myocardial stiffness.
    Klotz S; Foronjy RF; Dickstein ML; Gu A; Garrelds IM; Danser AH; Oz MC; D'Armiento J; Burkhoff D
    Circulation; 2005 Jul; 112(3):364-74. PubMed ID: 15998679
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Decreased myocardial chromogranin a expression and colocalization with brain natriuretic peptide during reverse cardiac remodeling after ventricular unloading.
    Wohlschlaeger J; von Winterfeld M; Milting H; El Banayosy A; Schmitz KJ; Takeda A; Takeda N; Azhari P; Schmid C; August C; Schmid KW; Baba HA
    J Heart Lung Transplant; 2008 Apr; 27(4):442-9. PubMed ID: 18374882
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Apoptosis, Bcl-2, and proliferating cell nuclear antigen in the failing human heart: observations made after implantation of left ventricular assist device.
    Francis GS; Anwar F; Bank AJ; Kubo SH; Jessurun J
    J Card Fail; 1999 Dec; 5(4):308-15. PubMed ID: 10634672
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dobutamine stress echocardiography predicts myocardial improvement in patients supported by left ventricular assist devices (LVADs): hemodynamic and histologic evidence of improvement before LVAD explantation.
    Khan T; Delgado RM; Radovancevic B; Torre-Amione G; Abrams J; Miller K; Myers T; Okerberg K; Stetson SJ; Gregoric I; Hernandez A; Frazier OH
    J Heart Lung Transplant; 2003 Feb; 22(2):137-46. PubMed ID: 12581761
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Resolution of Mitral Regurgitation With Left Ventricular Assist Device Support.
    Goodwin M; Nemeh HW; Borgi J; Paone G; Morgan JA
    Ann Thorac Surg; 2017 Sep; 104(3):811-818. PubMed ID: 28527962
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A pilot trial to assess potential effects of selective intracoronary bone marrow-derived progenitor cell infusion in patients with nonischemic dilated cardiomyopathy: final 1-year results of the transplantation of progenitor cells and functional regeneration enhancement pilot trial in patients with nonischemic dilated cardiomyopathy.
    Fischer-Rasokat U; Assmus B; Seeger FH; Honold J; Leistner D; Fichtlscherer S; Schächinger V; Tonn T; Martin H; Dimmeler S; Zeiher AM
    Circ Heart Fail; 2009 Sep; 2(5):417-23. PubMed ID: 19808371
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Osteopontin: a potential biomarker for heart failure and reverse remodeling after left ventricular assist device support.
    Schipper ME; Scheenstra MR; van Kuik J; van Wichen DF; van der Weide P; Dullens HF; Lahpor J; de Jonge N; De Weger RA
    J Heart Lung Transplant; 2011 Jul; 30(7):805-10. PubMed ID: 21531579
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical Outcomes of Autologous Stem Cell-Patch Implantation for Patients With Heart Failure With Nonischemic Dilated Cardiomyopathy.
    Domae K; Miyagawa S; Yoshikawa Y; Fukushima S; Hata H; Saito S; Kainuma S; Kashiyama N; Iseoka H; Ito E; Harada A; Takeda M; Sakata Y; Toda K; Pak K; Yamada T; Sawa Y
    J Am Heart Assoc; 2021 Jul; 10(13):e008649. PubMed ID: 34212772
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cardiomyopathic etiology and SERCA2a reverse remodeling during mechanical support of the failing human heart.
    Heerdt PM; Klotz S; Burkhoff D
    Anesth Analg; 2006 Jan; 102(1):32-7. PubMed ID: 16368801
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Left ventricular assist device support normalizes left and right ventricular beta-adrenergic pathway properties.
    Klotz S; Barbone A; Reiken S; Holmes JW; Naka Y; Oz MC; Marks AR; Burkhoff D
    J Am Coll Cardiol; 2005 Mar; 45(5):668-76. PubMed ID: 15734609
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Circulating growth differentiation factor-15 correlates with myocardial fibrosis in patients with non-ischaemic dilated cardiomyopathy and decreases rapidly after left ventricular assist device support.
    Lok SI; Winkens B; Goldschmeding R; van Geffen AJ; Nous FM; van Kuik J; van der Weide P; Klöpping C; Kirkels JH; Lahpor JR; Doevendans PA; de Jonge N; de Weger RA
    Eur J Heart Fail; 2012 Nov; 14(11):1249-56. PubMed ID: 22843564
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Myocardial size and fibrosis changes during left ventricular assist device support.
    Yamada Y; Saito S; Nishinaka T; Yamazaki K
    ASAIO J; 2012; 58(4):402-6. PubMed ID: 22739784
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sarcomeric genes involved in reverse remodeling of the heart during left ventricular assist device support.
    Rodrigue-Way A; Burkhoff D; Geesaman BJ; Golden S; Xu J; Pollman MJ; Donoghue M; Jeyaseelan R; Houser S; Breitbart RE; Marks A; Acton S
    J Heart Lung Transplant; 2005 Jan; 24(1):73-80. PubMed ID: 15653383
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reverse electrophysiologic remodeling after cardiac mechanical unloading for end-stage nonischemic cardiomyopathy.
    Drakos SG; Terrovitis JV; Nanas JN; Charitos EI; Ntalianis AS; Malliaras KG; Diakos N; Koudoumas D; Theodoropoulos S; Yacoub MH; Anastasiou-Nana MI
    Ann Thorac Surg; 2011 Mar; 91(3):764-9. PubMed ID: 21352994
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.